|
Advanced Cell Diagnostics Inc
probe 3-plex dapb ![]() Probe 3 Plex Dapb, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/probe 3-plex dapb/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
probe 3-plex dapb - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
3-plex dapb negative control probe (catalog 320878 ![]() 3 Plex Dapb Negative Control Probe (Catalog 320878, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/3-plex dapb negative control probe (catalog 320878/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
3-plex dapb negative control probe (catalog 320878 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
3-plex negative control probes ( dapb of bacillus subtilis strain) ![]() 3 Plex Negative Control Probes ( Dapb Of Bacillus Subtilis Strain), supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/3-plex negative control probes ( dapb of bacillus subtilis strain)/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
3-plex negative control probes ( dapb of bacillus subtilis strain) - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
dapb of bacillus subtilis strain 3-plex negative control probes ![]() Dapb Of Bacillus Subtilis Strain 3 Plex Negative Control Probes, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dapb of bacillus subtilis strain 3-plex negative control probes/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
dapb of bacillus subtilis strain 3-plex negative control probes - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
3-plex negative control probe dapb ![]() 3 Plex Negative Control Probe Dapb, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/3-plex negative control probe dapb/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
3-plex negative control probe dapb - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
3plex dapb probes ![]() 3plex Dapb Probes, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/3plex dapb probes/product/Bio-Techne corporation Average 86 stars, based on 1 article reviews
3plex dapb probes - by Bioz Stars,
2026-04
86/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
rnascope 3-plex positive control probe (polr2a-c1, ppib-c2 ![]() Rnascope 3 Plex Positive Control Probe (Polr2a C1, Ppib C2, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rnascope 3-plex positive control probe (polr2a-c1, ppib-c2/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
rnascope 3-plex positive control probe (polr2a-c1, ppib-c2 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
rish cxcl15 experimental probe ![]() Rish Cxcl15 Experimental Probe, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rish cxcl15 experimental probe/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
rish cxcl15 experimental probe - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Bio-Techne corporation
mm 3plex probes ![]() Mm 3plex Probes, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mm 3plex probes/product/Bio-Techne corporation Average 86 stars, based on 1 article reviews
mm 3plex probes - by Bioz Stars,
2026-04
86/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
hs-onecut1 (hnf6) #490081 ![]() Hs Onecut1 (Hnf6) #490081, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hs-onecut1 (hnf6) #490081/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
hs-onecut1 (hnf6) #490081 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
mm-tgfb2 ![]() Mm Tgfb2, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mm-tgfb2/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
mm-tgfb2 - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Advanced Cell Diagnostics Inc
probe specific to the bacterial dapb gene ![]() Probe Specific To The Bacterial Dapb Gene, supplied by Advanced Cell Diagnostics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/probe specific to the bacterial dapb gene/product/Advanced Cell Diagnostics Inc Average 90 stars, based on 1 article reviews
probe specific to the bacterial dapb gene - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Cell and Developmental Biology
Article Title: Spatial detection of mitochondrial DNA and RNA in tissues
doi: 10.3389/fcell.2024.1346778
Figure Lengend Snippet: Materials and Equipment.
Article Snippet:
Techniques: Hybridization, Multiplex Assay, Blocking Assay, Plasmid Preparation, Microscopy, Spectrophotometry, Real-time Polymerase Chain Reaction, SYBR Green Assay
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, Androgen responsive prostate tumor cells progressed from castration-sensitive (CS) to androgen responsive (pADT), and eventually developed castration-resistance (CR). CR was tumor size defined as ≥ 30% of nadir tumor volume. Top, tumor growth curve of MCRedAL tumors (n=3 mice per group, repeated x2); bottom: treatment and harvest timeline. CTX: Castration. b, Upper: sorting strategy to isolate tumor epithelial cells from a based on their expression of mCherry and their CD45−CD11b−F4/80−phenotype; Lower: purity check of mCherry+ sorted cells. c, Histogram of log2 fold change comparisons (SD Log2 FC) between pADT and CS groups among all the microarray transcripts (n=3 tumors per group). d, qRT-PCR quantification of Cxcl15 in Myc-CaP cells cultured at indicated concentrations of DHT for 8hrs and TNFα (50Units/ml) for 6hrs, cells cultured in androgen-free media for 48 hours before stimulation (n=2 independently cultured replicates per condition, repeated x2). Expression levels normalized to mean ΔCT level in samples cultured in androgen free media without TNFα or DHT. e, qRT-PCR quantification of Cxcl15 in Myc-CaP WT cells expressing either nothing, scramble (Scr) shRNA, or an anti-AR shRNA (KD: knock-down) cultured in the presence of DHT (10nM) for 8hrs and TNFα (50Units/ml) for 6hrs, cells cultured in androgen-free media for 24hrs before DHT stimulation (n=2 independently cultured replicates per condition, repeated x2). Expression levels normalized to mean ΔCT level in WT samples cultured in androgen free media without TNFα or DHT. f, qRT-PCR quantification of Cxcl15 in Myc-CaP cells cultured at indicated concentrations of DHT for 8hrs and TNFα (50Units/ml) for 6hrs in the presence and absence of the AR blocker Enzalutamide (10µM), cells cultured in androgen-free media for 48hrs before stimulation (n=2 independently cultured replicates per condition, repeated x2). Bar plots represent means with SEM. Unpaired two-tailed (d-f) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns).
Article Snippet:
Techniques: Expressing, Microarray, Quantitative RT-PCR, Cell Culture, shRNA, Knockdown, Two Tailed Test
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, Differential expression profile of tumor epithelial cells isolated from castration-sensitive (CS) and ADT-treated MCRedAL tumor bearing mice. Heatmap showing transcripts 3 standard deviations away from the mean (n=3 biologically-independent samples per group). b, Differential chemokine expression of tumor epithelial cells isolated from CS and pADT tumor bearing mice, replicates as in a. Left, volcano plot showing differential gene expression among all MTA 1.0 microarray transcripts. Right, heatmap of normalized chemokine transcripts. c, Hallmarks gene sets pathway analysis post-ADT shows NF-κB up-regulation by castration. d, Gene and protein expression of Cxcl15 in indicated sorted MCRedAL tumor cells in vitro by qRT-PCR (p=0.0237) and ELISA (p=0.0436), respectively, replicates as in a. e, qRT-PCR quantification of Cxcl15 in Myc-CaP cells cultured at indicated concentrations of DHT for 8hrs, cells cultured in androgen-free media for 48hrs before DHT stimulation (n=2 independently cultured replicates per condition, repeated x2). Expression levels normalized to mean ∆CT level in samples cultured in androgen free media without DHT. f, Percentage input bound in ChIP-qPCR assays assessing binding of AR, pSer5 Pol II, and H3K9ac at the Cxcl15 promoter in Myc-CaP cells cultured at indicated concentrations of DHT for 8hrs, cells cultured in androgen-free media for 48hrs before DHT stimulation (n=2 technical replicates per group, repeated x1). g, Percentage input bound in ChIP-qPCR assays assessing binding of AR, pSer5 Pol II, and H3K9ac at the Cxcl15 promoter in Myc-CaP cells cultured at indicated concentrations of DHT for 8hrs and TNFα (50Units/ml) for 6hrs, cells cultured in androgen-free media for 48hrs before DHT stimulation (replicates as in f). h, qRT-PCR quantification of Cxcl15 in Myc-CaP WT cells expressing either nothing, scramble (Scr) shRNA, or an anti-AR shRNA (KD: knockdown) cultured at indicated concentrations of DHT for 8hrs, cells cultured in androgen-free media for 24hrs before DHT stimulation (n=2 independently cultured replicates per condition, repeated x2). Expression levels normalized to mean ∆CT level in WT samples cultured in androgen free media without DHT. Bar plots represent means with SEM. Unpaired one-tailed t-tests were performed.
Article Snippet:
Techniques: Quantitative Proteomics, Isolation, Expressing, Gene Expression, Microarray, In Vitro, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Cell Culture, ChIP-qPCR, Binding Assay, shRNA, Knockdown, One-tailed Test
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, Representative images of Cxcl15 in Myc-CaP tumors. Tumors were harvested at ~500mm3 (CS group) or at the time of castration-resistance (CR), and hybridized with probe sets (white) to Cxcl15, anti-PanCK antibody (red), and anti-CD45 antibody (green). Nuclei were counterstained with DAPI (blue). b, Gene expression of Cxcl15 in sorted MCRedAL cells and protein expression in tumor lysates of indicated tumor samples by qRT-PCR (left) and ELISA (right), respectively (n=2 biologically-independent samples per group, repeated x2). c, qRT-PCR quantification of IL-8 in human AR positive castration-sensitive cells (CS: LNCaP, LAPC4, and VCaP) and their castration-resistant counterparts (CR: LNCaP-abl, LAPC4-CR, and VCaP-CR; n=2 technical replicates, repeated x2). d, IL-8 protein expression in isogenic cell pairs from c quantified by MSD (n=3 independently cultured replicates per condition, repeated x2). e, Representative images of Cxcl15 fluorescent detection in benign murine prostate tissue samples from castration-sensitive (CS), androgen-deprivation treated (pADT), and ADT-treated mice that received testosterone repletion (pADT + T). Tissue sections hybridized with probe sets (white) to Cxcl15, and anti-PanCK antibody (red). Nuclei were counterstained with DAPI (blue). f, qRT-PCR analysis of Cxcl15 expression in prostate luminal epithelial cells (PLECs) from indicated treatment groups (p=0.0074 CS vs pADT and p=0.0131 pADT vs pADT+T; n=3 biologically-independent samples per group). PLECs were isolated based on their GFP+CD49fintCD24+CD45−F4/80−CD11b−expression by flow sorting. g, Expression of IL-8 in human prostate epithelial cells micro-dissected from patients (NCT00161486) receiving placebo, androgen-deprivation treatment (pADT), or ADT plus testosterone repletion (pADT + T). Z-score values of microarray transcripts from benign prostate biopsies were normalized to placebo (p=0.0143 pADT vs pADT+T; n=4 biologically-independent samples per group; GSE8466). h, Representative images of IL-8 colorimetric detection in human prostate tumor specimens from untreated or ADT-treated (NCT01696877). i, Expression of IL-8 in human prostate cancer epithelial cells micro-dissected from untreated or ADT-treated (p=0.0148 Untreated vs pADT; n=8 biologically-independent samples per group) patients as determined by qRT-PCR. Images representative of 3 independent experiments. RISH images are at 60X magnification; scale bar=100 μm. Gene expression levels were normalized to CS, untreated or placebo samples. Bar plots represent means with SEM. Unpaired two-tailed (d-f) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns). For c & f, Log2 transformed values were used. For g & i, a Mann-Whitney U test was used due to the non-normal data distribution observed. The box plot includes 25th to 75th of all IL-8 expression values with horizontal line indicating the median values. The whiskers represent the highest values, including outliers and extremes.
Article Snippet:
Techniques: Gene Expression, Expressing, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Cell Culture, Isolation, Microarray, Two Tailed Test, Transformation Assay, MANN-WHITNEY
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, Representative images of positive and negative controls (cnts: murine and bacteria probe, respectively) in Myc-CaP tumors from indicated treatment groups highlight the specificity of RNA In situ hybridization independently of treatment groups. Tumors were harvested when tumor volume reached ~500mm3 (CS group) or at the time of castration-resistance (CR). Prostate tumor tissue sections were hybridized with CF568-labeled probe sets (white) to Cxcl15, CF640-labeled anti-PanCK antibody (red), and CF488-labeled anti-CD45 antibody (green). Nuclei were counterstained with DAPI (blue). b, qRT-PCR quantification of IL-8 in AR positive castration-sensitive (LNCaP, LAPC4, and VCaP) and AR independent castration-resistant (CWR22Rv1, DU145, and PC3) human prostate cancer cell lines (n=2 independently cultured replicates per group, repeated x2). IL-8 expression levels were normalized to mean ΔCT level in DU145 samples. c, CXCL1, CXCL2, CXCL5, and CXCL12 protein expression in human AR positive castration-sensitive LNCaP cell line (CS) and it’s isogenic castration-resistant counterpart LNCaP-abl (CR) quantified by MSD (n=3 independently cultured replicates per group, repeated x1). d, IL-8 protein expression in LNCaP and AR-independent PC3 human prostate cancer cell lines quantified by MSD, replicates as in c. e, Treatment scheme for GFP induction with Doxycycline (DOX) in transgenic Hoxb13-rtTA|TetO-H2BGFP mice for specific isolation of benign murine prostate epithelial cells from castration-sensitive (CS), androgen-deprivation treated (pADT) non-tumor bearing mice, and ADT-treated mice that received testosterone repletion (pADT + T). f, IL-8-RISH quantification in human prostate tumor specimens from untreated (n=20 patients) or ADT-treated (n=15 patients; NCT01696877). Quantification was restricted to tumor areas and represented as number of positive cells per mm2. Images representative of 3 independent experiments. RISH images are 60X magnification; scale bar=100 μm. For b, Tukey’s multiple comparisons test with a single pooled variance was performed, p-values ≤ 0.0001 (****). Bar plots represent means with SEM. Unpaired two-tailed (c-d) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns). For f a Mann-Whitney U test was used due to the non-normal data distribution observed. The box plot includes 25th to 75th of all IL-8 positive cells/mm2 values with horizontal line indicating the median values. The whiskers represent the highest values, including outliers and extremes.
Article Snippet:
Techniques: Expressing, Bacteria, RNA In Situ Hybridization, Labeling, Quantitative RT-PCR, Cell Culture, Transgenic Assay, Isolation, Two Tailed Test, MANN-WHITNEY
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, Gating strategy used to profile the immune compartment of the TME by flow cytometry. Tumor associated macrophages (TAMs) gated based on CD45+Ly6G−F4/80+CD11b+, Inflammatory (Inf.) TAMs as CD45+CD11b+F4/80+Ly6C+MHCII−, immature (Imm.) TAMs as CD45+CD11b+F4/80+Ly6C+MHCII+, MHCIIhi TAMs as CD45+CD11b+F4/80+Ly6C−MHCII+, MHCIIlow TAMs as CD45+CD11b+F4/80+Ly6C−MHCII−, tumor Infiltrating Lymphocytes (TILs) CD45+CD4+ or CD45+CD8+, tumor infiltrating polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) as CD45+CD11b+Ly6C+Ly6G+. b, TAM, TIL, and PMN-MDSC density normalized to mg of tumor weight (cells/mg; p=0.0189 CD4, p=0.0093 CD8, and p=0.0099 PMN-MDSCs; Myeloid cells: n=4 CS, n=5 pADT, n=5 CR and T cells: n=3 CS, n=4 pADT, n=5 CR tumors per group, repeated x2). c, Representative H&E and immunohistochemistry (F4/80 and Ly6G) of indicated murine allografts (repeated x3). d, Normalized expression of selected genes determined by NanoString nCounter gene analysis in sorted myeloid fractions defined as in a (n=3 tumors per group). e, qRT-PCR quantification of Cxcr2 and Il-23 in indicated populations of Myc-CaP tumors (Imm.: n=3 CS & CR, MHCIIhi: n=3 CS & CR, MHCIIlow: n=3 CS & n=2 CR, and PMN-MDSCs: n=2 CS & n=3 CR tumors per group). f and g, Density of PMN-MDSCs normalized to mg of tumor weight (cells/mg) in Myc-CaP (p=0.0054 anti-CXCR2; n=7 isotype and n=5 anti-CXCR2 tumors per group; p=0.0033 Cxcl15 KO; n=4 WT and n=6 Cxcl15 KO tumors per group, repeated x2) and PC3 tumors (p<0.0001 anti-CXCR2; n=8 isotype and n=9 anti-CXCR2 tumors per group; p=0.0303 IL-8 KO; n=6 WT and n=4 IL-8 KO tumors per group, repeated x2). Cells quantified by flow cytometry as in a, tumors implanted and harvested as in materials and methods. H&E and IHC images at 40X magnification; scale bar=50 μm. Gene expression levels normalized to the mean ∆CT level in samples from the Immature TAMs (Imm.) group. Bar plots represent means with SEM. Unpaired two-tailed (f-g) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns). Tukey’s (b) multiple comparisons test were performed for one-way and two-way ANOVAs respectively.
Article Snippet:
Techniques: Flow Cytometry, Derivative Assay, Immunohistochemistry, Expressing, Quantitative RT-PCR, Gene Expression, Two Tailed Test
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a, PMN-MDSCs as a percentage of CD45+ cells in the TME of indicated human prostate tumors as determined by flow cytometry (n=3 LNCaP and n=6 PC3 tumors per group, 2 independent experiments). b, Representative H&E and immunohistochemistry (Ly6G and F4/80) sections of the indicated human prostate xenografts (repeated x3). c, Dorsal prostate transgenic NPK tumors (p=0.0493) and d, Anterior prostate transgenic NPK tumor (p=0.0006). Left: representative H&E and immunohistochemistry of Ly6G in transgenic NPK tamoxifen-inducible prostate tumors harvested from untreated (CS group) or ADT-treated mice (CR group). CTX (degarelix) was administrated 3 months after tamoxifen-induction, and tumors were harvest 30 days later; right: Ly6G positive counts per mm2 of tumor area as described in the methods section. e, PMN-MDSC density normalized to mg of tumor weight in transgenic NPK tamoxifen-inducible prostate tumors from mice treated as described in c-d (p=0.0208; cells/mg; n=4 CS & n=3 CR tumors per group). f, Left: representative H&E and immunohistochemistry of Ly6G in non-cancerous murine prostate from castration-sensitive (CS), androgen-deprivation treated (pADT) non-tumor bearing mice, and ADT-treated mice that received testosterone repletion (pADT + T). Repeated x2; right: counts of Ly6G positive cells per field as described in the methods section. g, Representative histograms of protein expression determined by flow cytometry in PMN-MDSCs from indicated organs (repeated x2). h, Representative H&E and immunohistochemistry (Ly6G and F4/80) on CR-Myc-CaP allografts treated as indicated (repeated x3). i, Representative H&E and immunohistochemistry (Ly6G and F4/80) in PC3 tumor xenografts treated as indicated (repeated x3). H&E and IHC images are 40X magnification; scale bar=50 μm. Bar plots represent means with SEM. Unpaired two-tailed (a-e) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns). For f, Tukey’s multiple comparisons test with a single pooled variance was performed.
Article Snippet:
Techniques: Flow Cytometry, Immunohistochemistry, Transgenic Assay, Expressing, Two Tailed Test
Journal: Nature cancer
Article Title: Castration-mediated IL-8 Promotes Myeloid Infiltration and Prostate Cancer Progression
doi: 10.1038/s43018-021-00227-3
Figure Lengend Snippet: a-c, Analyses of Cxcl15 driven Ly6G+ PMNs migration to the peritoneum in animals pretreated with either isotype or anti-CXCR2 (n=5 PBS, n=4 isotype, and n=4 anti-CXCR2 mice per group, repeated x2). a, Cell numbers (p=0.0015). b, Fold change calculated as the number of Ly6G+ PMNs in peritoneal washings divided by PMN numbers in peripheral blood (p=0.0008). c, Representative flow plots of Ly6G+ PMNs in peritoneal washings d, PMN-MDSC in vitro migration towards tumor supernatants in the presence of either isotype, anti-CXCR2, or anti-IL-8 (200µg/ml). Antibodies were added at the beginning of the experiment (p=0.0304 CR-MCRedAL, p=0.0015 anti-CXCR2 and p=0.0006 anti-IL-8 for PC3 supernatant; n=3 independent assays per group, repeated x2). e, PMN-MDSC in vitro migration towards CR-LNCaP (also known as LNCaP-abl) WT or IL-8 KO tumor supernatants (left; p=0.0034) and towards WT supernatants in the presence of either isotype, anti-CXCR2, or anti-IL-8 (200µg/ml; right; p=0.0018 anti-CXCR2 and p=0.005 anti-IL-8) (n=3 independent assays per group, repeated x2). f, Schematic representation of PMN-MDSC suppression assay. OT-I splenocytes (CD45.2) were mixed with naïve splenocytes (CD45.1) in a 1:10 ratio, labeled with CTV, and co-cultured with PMN-MDSCs at the indicated ratios. Antigen-specific T cell proliferation stimulated (Stim) by OVA peptide (5pM) for 60hrs. g, Percent suppression with either unselected or low-density PMN-MDSCs (p=0.0101 1:2, 0.0002 1:4, and p=0.0051 1:8; n=3 independent assays per group, repeated x3). h, Percentage of CD8 T cells (left; p<0.0001 1:1–1:8 and p=0.0055 1:16) and antigen specific OT-I cells (CD45.2; right; p<0.0001 1:1–1:2 and p=0.0002 1:4) proliferating at different proportions of PMN-MDSCs when stimulated with or without 5pM of OVA, replicate numbers as in g. i, Representative histograms of antigen specific OT-I cell proliferation based on the dilution of CTV dye when stimulated as in h (repeated x2). j, Percent suppression in the presence of either isotype or anti-CXCR2 (200µg/ml). Antibodies were added at the beginning of the experiment (n=3 independent assays per group, repeated x2). k, Percent suppression of PMN-MDSCs derived from spleens of WT or Cxcl15 KO Myc-CaP tumor bearing mice (n=3 independent assays per group, repeated x2). Bar plots represent means with SEM. Unpaired two-tailed (a-g, j-k) t-tests were performed, p-values ≤ 0.0001 (****); p-values ≥ 0.05 (ns). For h, Tukey’s multiple comparisons test with a single pooled variance was performed.
Article Snippet:
Techniques: Migration, In Vitro, Suppression Assay, Labeling, Cell Culture, Derivative Assay, Two Tailed Test
Journal: EMBO Reports
Article Title: LATS1/2 inactivation in the mammary epithelium drives the evolution of a tumor-associated niche
doi: 10.1038/s44319-025-00370-3
Figure Lengend Snippet: Reagents and tools table
Article Snippet: The probes used were obtained from
Techniques: Electron Microscopy, Plasmid Preparation, Blocking Assay, RNAscope, Multiplex Assay, Positive Control, Negative Control, Staining, cDNA Synthesis, SYBR Green Assay, Membrane, Software, Real-time Polymerase Chain Reaction